Literature DB >> 16834858

Antiphospholipid syndrome: a series of surgical emergencies and the current evidence for its management.

A E Agaba1, N Charaklias, A Babu-Victor, P O Agaba, V Deepchand, H S Dabasia, S S Sharma, M J Goodrick, B Ramanand.   

Abstract

It is generally accepted that antiphospholipid syndrome remains a major medical problem characterised by hypercoagulability, arterial and venous thrombosis and thrombocytopenia. It is unclear how best to treat these patients should they require emergency surgery. If a lupus anticoagulant is present, hypercoagulability may occur de novo but surgical interventions along with sepsis are two important predisposing factors. We describe three patients with primary antiphospholipid syndrome and discuss the implications for surgery.

Entities:  

Mesh:

Year:  2006        PMID: 16834858      PMCID: PMC1964613          DOI: 10.1308/003588406X106496

Source DB:  PubMed          Journal:  Ann R Coll Surg Engl        ISSN: 0035-8843            Impact factor:   1.891


  19 in total

1.  A comparison of two intensities of warfarin for the prevention of recurrent thrombosis in patients with the antiphospholipid antibody syndrome.

Authors:  Mark A Crowther; Jeff S Ginsberg; Jim Julian; Judah Denburg; Jack Hirsh; James Douketis; Carl Laskin; Paul Fortin; David Anderson; Clive Kearon; Ann Clarke; William Geerts; Melissa Forgie; David Green; Lorrie Costantini; Wendy Yacura; Sarah Wilson; Michael Gent; Michael J Kovacs
Journal:  N Engl J Med       Date:  2003-09-18       Impact factor: 91.245

Review 2.  Management of the obstetric antiphospholipid syndrome.

Authors:  Ronald H W M Derksen; Munther A Khamashta; D Ware Branch
Journal:  Arthritis Rheum       Date:  2004-04

Review 3.  The catastrophic antiphospholipid syndrome.

Authors:  R A Asherson
Journal:  J Rheumatol       Date:  1992-04       Impact factor: 4.666

4.  An acute disseminated coagulopathy-vasculopathy associated with the antiphospholipid syndrome.

Authors:  E N Harris; K Bos
Journal:  Arch Intern Med       Date:  1991-02

5.  Combined use of aspirin and warfarin in primary prevention of ischemic heart disease in men at high risk.

Authors:  T W Meade; G J Miller
Journal:  Am J Cardiol       Date:  1995-02-23       Impact factor: 2.778

6.  Antiphospholipid thrombosis: clinical course after the first thrombotic event in 70 patients.

Authors:  M H Rosove; P M Brewer
Journal:  Ann Intern Med       Date:  1992-08-15       Impact factor: 25.391

7.  Anti-phospholipid antibodies are directed against a complex antigen that includes a lipid-binding inhibitor of coagulation: beta 2-glycoprotein I (apolipoprotein H).

Authors:  H P McNeil; R J Simpson; C N Chesterman; S A Krilis
Journal:  Proc Natl Acad Sci U S A       Date:  1990-06       Impact factor: 11.205

8.  Patients with antiphospholipid antibodies and venous thrombosis should receive long term anticoagulant treatment.

Authors:  R H Derksen; P G de Groot; L Kater; H K Nieuwenhuis
Journal:  Ann Rheum Dis       Date:  1993-09       Impact factor: 19.103

9.  Anticardiolipin antibodies and the risk for ischemic stroke and venous thrombosis.

Authors:  K S Ginsburg; M H Liang; L Newcomer; S Z Goldhaber; P H Schur; C H Hennekens; M J Stampfer
Journal:  Ann Intern Med       Date:  1992-12-15       Impact factor: 25.391

10.  The management of thrombosis in the antiphospholipid-antibody syndrome.

Authors:  M A Khamashta; M J Cuadrado; F Mujic; N A Taub; B J Hunt; G R Hughes
Journal:  N Engl J Med       Date:  1995-04-13       Impact factor: 91.245

View more
  1 in total

1.  Anaesthetic considerations for patients with antiphospholipid syndrome undergoing non-cardiac surgery.

Authors:  Jae Won Kim; Tae Woo Kim; Keon Hee Ryu; Sun Gyoo Park; Chang Young Jeong; Dong Ho Park
Journal:  J Int Med Res       Date:  2020-01       Impact factor: 1.671

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.